Metabolomics Market Report 2026

Metabolomics Market Overview

• Metabolomics market size has reached to $4.17 billion in 2025 • Expected to grow to $9.29 billion in 2030 at a compound annual growth rate (CAGR) of 17.3% • Growth Driver: Rising Prevalence Of Cancers Fueling The Market Growth Due To Increasing Life Expectancy • Market Trend: Advancements In Metabolomics The Role Of Integrated Bioinformatics Platforms • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Metabolomics Market?

Metabolomics is the study of small molecules called metabolites that are produced during metabolism within cells, tissues, or organisms. It provides insights into biological processes, disease mechanisms, and metabolic pathways by analyzing and quantifying these metabolites. This field is crucial in personalized medicine, drug discovery, and understanding various diseases like cancer and diabetes. The main products and services of metabolomics are metabolomics instruments, metabolomics bioinformatics tools, and services. Metabolomics instruments are devices used to extensively examine low-molecular-weight compounds in biological samples. The various metabolomics instruments include separation techniques, detection techniques, and metabolomics bioinformatics tools and services involving bioinformatics tools and databases, as well as bioinformatics services. The different indications are cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism, and others that are applied in biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, personalized medicine, and others.

What Is The Metabolomics Market Growth Forecast?

The metabolomics market size is expected to see rapid growth in the next few years. It will grow to $9.29 billion in 2030 at a compound annual growth rate (CAGR) of 17.3%. The growth in the forecast period can be attributed to advances in bioinformatics tools, rising focus on personalized medicine, increasing demand for nutrigenomics applications, growth in metabolic pathway research, expanding clinical diagnostics integration. Major trends in the forecast period include integration of precision medicine with metabolomic profiling, expansion of cloud-based metabolomics data platforms, AI-driven metabolite pattern recognition, automation in high-throughput metabolomics workflows, iot-enabled real-time metabolic monitoring.

Global Metabolomics Market Segmentation

1) By Product And Service: Metabolomics Instruments, Metabolomics Bioinformatics Tools And Services 2) By Indication: Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors Of Metabolism, Other Indications 3) By Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, Other Applications Subsegments: 1) By Metabolomics Instruments: Chromatography Instruments (Gas Chromatography, Liquid Chromatography), Mass Spectrometry Instruments (LC-MS, GC-MS), NMR Instruments (Nuclear Magnetic Resonance) 2) By Metabolomics Bioinformatics Tools And Services: Software Tools (Data Analysis, Statistical Tools, Modeling Tools), Database Services (Metabolomic Databases), Consulting Services (Data Interpretation, Analytical Support), Training And Support Services

What Is The Driver Of The Metabolomics Market?

The rising prevalence of cancer is expected to propel the growth of the metabolomics market going forward. Cancer is a group of diseases where abnormal cells grow uncontrollably, invade tissues, and can spread to other parts of the body. The increasing cancer prevalence is due to aging population, as advanced age is the most significant risk factor for developing most types of cancer, with the majority of cases occurring in individuals over 65 years old. Metabolomics helps cancer research by providing a comprehensive snapshot of metabolic changes in tumor cells, enabling early detection, understanding of disease mechanisms, and identification of potential therapeutic targets. For instance, in February 2024, according to the World Health Organization, a Switzerland-based international organization specializing in global health policy and public health initiatives, over 35 million new cancer cases are predicted in 2050, a 77% increase from the estimated 20 million cases in 2022. Therefore, the rising prevalence of cancers is driving the growth of the metabolomics industry.

Key Players In The Global Metabolomics Market

Major companies operating in the metabolomics market are Human Metabolome Technologies Inc., Metabolon Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Agilent Technologies Inc., Thermo Fisher Scientific Inc., Waters Corporation, Biocrates Life Sciences AG, Shimadzu Corporation, Danaher Corporation, PerkinElmer Inc., LECO Corporation, Phenomenome Discoveries Inc., AB Sciex, BG Medicine Inc., Chenomx Inc., Creative Proteomics, Evotec A.G, Merck kgaA, Charles River Laboratories International Inc., Metabowerke GmbH, Metabolomic Diagnostics, Phenomenex Inc.

Global Metabolomics Market Trends and Insights

Major companies operating in the metabolomics market focus on introducing Integrated Bioinformatics Platforms to improve the interpretation of complex metabolomic data, thereby facilitating advancements in personalized medicine, biomarker discovery, and disease understanding. Integrated Bioinformatics Platform refers to a comprehensive software solution that combines various bioinformatics tools and databases to facilitate the analysis and interpretation of biological data. Researchers can index metabolomics data against Metabolon's precise biochemical pathway maps, which helps uncover biological processes and disease mechanisms. For instance, in February 2024, Metabolon, Inc., a US-based company, launched Metabolon’s bioinformatics platform. Biomarker Lenses in the Integrated Bioinformatics Platform enables users to apply advanced analytical filters to focus on metabolites linked to specific pathways or diseases, facilitating a more targeted exploration of metabolomic data. The platform includes tools for conducting statistical analyses such as T-tests and ANOVAs, allowing researchers to build and compare statistical models, manage metadata, and visualize results effectively.

What Are Latest Mergers And Acquisitions In The Metabolomics Market?

In June 2025, Bruker Corporation, a US-based scientific instruments and life‑science technology company, acquired biocrates life sciences ag for an undisclosed amount. With this acquisition, Bruker aims to strengthen its multiomics offering by integrating metabolomics thus broadening its product lineup beyond instruments to include standardized metabolite‑analysis kits, assays, software and services. Biocrates Life Sciences Ag is an Austria‑based life‑science technology company that specializes in mass‑spectrometry‑based quantitative metabolite and lipid analysis, offering standardized kits, software and contract research services that allow labs to quantify hundreds to thousands of metabolites from small biological samples.

Regional Outlook

North America was the largest region in the metabolomics market in 2025. Western Europe was the second largest region in the metabolomics market. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Metabolomics Market?

The metabolomics market includes revenue earned by liquid chromatography, gas chromatography, capillary electrophoresis, mass spectrometry, and nuclear magnetic resonance spectroscopy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Metabolomics Market Report 2026?

The metabolomics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the metabolomics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.